Sun Yat-sen University Cancer Center ( Chinese : 中山大学肿瘤防治中心; ; pinyin : Zhōngshān Dàxué Zhǒngliú Fángzhì Zhōngxīn ), abbreviated as SYSUCC, is a public hospital in Guangzhou , China. It is affiliated with Sun Yat-sen University .
30-703: The hospital was founded in March 1964. It is a Level III Class A hospital (the highest rank in China) and the largest integrated cancer center in southern China for care, research, education and prevention. SYSUCC is ranked among the top three cancer center's in China, and is one of the best in Asia. The current President of the center is Dr. Xu Ruihua . SYSUCC is a member of the Union for International Cancer Control (UICC). The predecessor of SYSUCC
60-764: A Board of Directors with 16 directors, elected at the general assembly , act as the executive body of UICC. At its head is the President of UICC, a position currently held by Prof Anil D’Cruz from India. The organisation is managed by the CEO with a staff of some 40 employees, based in Geneva, Switzerland. The current CEO is Cary Adams, who has held this position since 2009. Member organisations, partners and other networks UICC’s more than 1,150 members include cancer societies, governmental agencies, treatment and research centres, patient support groups and professional associations from around
90-470: A biobank to collect peripheral blood, bone marrow, and tissue samples after surgery, along with other clinical information from cancer patients. They have the largest number of nasopharyngeal carcinoma samples in the world. SYSUCC is establishing a new automatic bio-sample storage retrieval system capable of storing up to 6 million samples. SYSUCC has its own Clinical Trials Center (CTC) to assist physicians and scientists to test new therapies. It includes
120-514: A National Clinical Study Center for Anticancer Drugs and a National Key Laboratory of Anti-cancer Drug Development. The CTC is CFDA certified. SYSUCC sponsors Cancer Communications, an oncology journal published in English formerly known as the Chinese Journal of Cancer. It publishes basic , clinical and translational cancer research. In 2014, it became Science Citation Indexed (SCI), it has
150-415: A broad five-year Memorandum of Understanding to carryout research on cancer diagnosis and treatment. Union for International Cancer Control The Union for International Cancer Control (previously named International Union Against Cancer ) or UICC is a non-governmental organisation with over 1,150 member organisations in more than 170 countries and territories. UICC was founded in 1933 and
180-429: A current Impact Factor (IF) of 3.822. The Editorial Board consists of members from around the world. SYSUCC has established collaborative and friendly relationships with many renowned international institutes from around the world. SYSUCC has been a sister institute with MD Anderson Cancer Center since 2003. The purpose is to create collaborative oncology research projects between MDACC and other sister institutes in
210-475: A mutual understanding or agreement, noting each party's requirements and responsibilities—but without establishing a formal, legally enforceable contract (though an MoU is often a first step towards the development of a formal contract). In the United Kingdom , the term MoU is commonly used to refer to an agreement between parts of The Crown . The term is often used in the context of devolution , for example
240-548: Is based in Geneva , Switzerland . Its member organisations feature cancer societies, governmental agencies, treatment and research centres, patient support groups and professional associations. UICC was established in Paris in 1933 following a proposal at a cancer congress in Madrid to create an international organisation that would "promote the fight against cancer through research, therapy and
270-469: Is that, because obligations under international law may be avoided, they can often be put into effect without requiring legislative approval. Hence, MoUs are often used to modify and adapt existing treaties, in which case these MoUs have factual treaty status. The decision concerning ratification, however, is determined by the parties' internal law and depends to a large degree on the subject agreed upon. MoUs that are kept confidential (i.e., not registered with
300-567: The Manual of Clinical Oncology with information on cancer detection, diagnosis and treatment, survivorship, special populations and palliative care. The open-access, online-only JCO Global Oncology is published in partnership with the American Society of Clinical Oncology since 2015. UICC is a non-governmental organisation governed by its member organisations, which meet in a general assembly held every two years. Between general assemblies
330-646: The State Key Laboratory of Oncology in South China (SKL), which is national recognition for the highest degree of expertise. It was founded in 2005 by the Ministry of Science and Technology in China. The laboratory is integrated into SYSUCC and its activities cover a broad spectrum in oncology from basic to translational and clinical research. There are 269 SKLs in China, 26 of them are dedicated to medicine and only seven are cancer related. In 2001, SYSUCC established
SECTION 10
#1732855961186360-708: The TNM Classification of Malignant Tumors in 1953 as the "Uniform Technique for a Clinical Classification by the TNM System", with the first pocket book edition issued in 1968. The Classification has been regularly updated and the 8th edition was published with John Wiley and Sons (Wiley) in 2017. The peer-reviewed medical journal, the International Journal of Cancer , has been the official journal of UICC since 1966 and covers topics relevant to experimental and clinical cancer research. UICC publishes with Wiley
390-491: The United Nations Office of Legal Affairs ' insistence that registration be done to avoid 'secret diplomacy', MoUs are sometimes kept confidential. As a matter of law, the title of MoU does not necessarily mean the document is binding or not binding under international law . To determine whether a particular MoU is meant to be a legally binding document (i.e., a treaty), one needs to examine the parties’ intent as well as
420-813: The World Health Organization (WHO), has consultative status with the United Nations Economic and Social Council , sits on the Governing Council of the International Agency for Research on Cancer , and works closely with the Programme of Action for Cancer Therapy (PACT) initiated by the International Atomic Energy Agency . Presidents of UICC The official mission statement of UICC reads: "UICC unites and supports
450-495: The cancer community to reduce the global cancer burden, to promote greater equity , and to ensure that cancer control continues to be a priority in the world health and development agenda." Its work on cancer control includes areas such as the elimination of cervical cancer , tobacco control , metastatic breast cancer , antimicrobial resistance , cancer and ageing , access to essential medicines , equity in healthcare , Universal Health Coverage and addressing cancer care in
480-547: The 1999 concordat between the central Department for Environment, Food and Rural Affairs and the Scottish Environment Directorate . MoUs can also be used between a government agency and a non-commercial, non-governmental organization. In international relations, MoUs fall under the broad category of treaties and should be registered in the United Nations treaty collection. In practice and in spite of
510-475: The Access to Oncology Medicines (ATOM) Coalition in 2022. Memorandum of Understanding A memorandum of understanding ( MoU ) is a type of agreement between two ( bilateral ) or more ( multilateral ) parties. It expresses a convergence of will between the parties, indicating an intended common line of action. It is often used either in cases where parties do not imply a legal commitment or in situations where
540-578: The French, Spanish and Latin texts. The 1933 cancer congress in Madrid was considered the first "International Cancer Congress" and the second was held in Brussels in 1936 under the auspices of UICC. The third took place in Atlantic City, US, in 1939 before the activities of UICC were suspended due to World Word II . The fourth and fifth congresses were held in 1947 and 1950 respectively. Thereafter and until 2006,
570-561: The US, the specifics can differ slightly depending on whether the contract is for goods (falls under the Uniform Commercial Code ) or services (falls under the common law of the state). Many companies and government agencies use MoUs to define a relationship between departments, agencies or closely held companies. In business , an MoU is typically a legally non-binding agreement between two (or more) parties, outlining terms and details of
600-499: The development of social activities." The organisation was given the Latin name Unio Internationalis Contra Cancrum , hence the acronym UICC, and the first General Assembly took place in Paris on 4 May 1935, with representatives from 67 national cancer organisations and 43 countries. The English name was changed in 2010 to its current name, Union for International Cancer Control so that the "UICC" acronym would be consistent with that for
630-724: The fight against cancer. In 2004, SYSUCC set up a joint laboratory with the Karolinska Institutet of Sweden for research in immunotherapy, molecular virology and oncological epidemiology. SYSUCC signed a Memorandum of Understanding (MoU) with the UK's University of Warwick in 2015, creating a partnership in cancer diagnosis, care and research. SYSUCC and the University of Warwick are exploring opportunities in regards to digital pathology, nursing, and anti-cancer drug research. In 2017, SYSUCC and Fred Hutchinson Cancer Research Center signed
SECTION 20
#1732855961186660-475: The international cancer congress – later named World Cancer Congress – and UICC’s General Assembly were held every four years; since 2006 they have been held every two years. The 2020 World Cancer Congress that was due to be held in Oman had to be called off because of the coronavirus pandemic. The organisation moved to Geneva in 1948 to be close to the global health organisations. Today, UICC has official relations with
690-637: The leadership of Liang Boqiang. In 1966, the name of the hospital was changed to the Affiliated Cancer Hospital of Sun Yat-sen Medical College. The name was later changed again in 1985, to the Affiliated Cancer Hospital of Sun Yat-sen Medical University. Twenty-three years after both their respective establishments, in 1987, the Cancer Hospital and the Cancer Institute merged under the name Sun Yat-sen Medical University Cancer Center. The name
720-449: The parties cannot create a legally enforceable agreement. It is a more formal alternative to a gentlemen's agreement . Whether a document constitutes a binding contract depends only on the presence or absence of well-defined legal elements in the text proper of the document (the so-called " four corners "). The required elements are offer and acceptance , consideration , and the intention to be legally bound ( animus contrahendi ). In
750-407: The signatories' position (e.g., Minister of Foreign Affairs vs. Minister of Environment). A careful analysis of the wording will also clarify the exact nature of the document. The International Court of Justice has provided some insight into the determination of the legal status of a document in the landmark case of Qatar v. Bahrain , 1 July 1994. One advantage of MoUs over more formal instruments
780-420: The time of the coronavirus pandemic. UICC convenes the cancer community at events (World Cancer Congress, World Cancer Leaders’ Summit), organises thematic webinars , provides training, fellowships and grants , and advocates for effective cancer control. It is also behind World Cancer Day , an official international awareness day marked every year on February 4 . Scientific publications UICC published
810-732: The world. UICC also works with over 60 partners, including other health organisations, foundations and private sector companies committed to reducing the global cancer burden. In addition, UICC is a founding member of the NCD Alliance , the McCabe Centre for Law & Cancer, and the International Cancer Control Partnership UICC established the City Cancer Challenge Foundation in January 2019 and
840-584: Was a professor and head of the radiology department since 1928, to chair the radiology department at Lingang University . Since the early 1950s and with the help of Ke Lin, the Dean of the Zhongshan Medical School, they later established the Tumor Hospital in South China. The hospital opened its doors in March 1964 under the leadership of Hsieh Chih Kuang. A few days later a Cancer Institute was opened under
870-468: Was simplified in 2001 to Sun Yat-sen University Cancer Center. According to the 2018 Nature Index report for global healthcare , the achievements of SYSUCC's active research environment were number 81 among the top 100 medical institutes in the world. "The Nature Index is a freely accessible database of author affiliation information collated from research articles published in an independently selected group of high-quality science journals." SYSUCC hosts
900-416: Was the Tumor Hospital in South China. The founders were Professor Hsieh Chih Kuang ( 谢志光 ), a pioneer of clinical radiology and the founding father of radiation oncology in China, and Professor Liang Boqiang ( 梁伯强 ), the originator of modern pathology in China. In 1948, Hsieh Chih Kuang (Medical Doctor from University of Connecticut 1922) was recruited from PUMC ( Peking Union Medical College ), where he
#185814